{"id":"https://openalex.org/W1952010211","doi":"https://doi.org/10.1002/mds.26362","title":"New treatments for levodopa\u2010induced motor complications","display_name":"New treatments for levodopa\u2010induced motor complications","alternate_titles":[],"publication_year":2015,"publication_date":"2015-08-21","ids":{"openalex":"https://openalex.org/W1952010211","doi":"https://doi.org/10.1002/mds.26362","mag":"1952010211","pmid":"https://pubmed.ncbi.nlm.nih.gov/26293004"},"language":"en","primary_location":{"id":"doi:10.1002/mds.26362","doi":"https://doi.org/10.1002/mds.26362","is_oa":false,"landing_page_url":"https://doi.org/10.1002/mds.26362","pdf_url":null,"source":{"id":"https://openalex.org/S163027424","display_name":"Movement Disorders","issn_l":"0885-3185","issn":["0885-3185","1531-8257"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1952010211"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054027214","display_name":"Olivier Rascol","orcid":"https://orcid.org/0000-0002-1410-6397","observed_orcids":["https://orcid.org/0000-0002-1410-6397"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I4405264399","display_name":"Toulouse NeuroImaging Center","ror":"https://ror.org/01t1x3s61","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4405258862","https://openalex.org/I4405264399"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Olivier Rascol","raw_affiliation_strings":["Department of Clinical Pharmacology and Neurosciences; University Hospital and University of Toulouse 3; France","INSERM CIC1436 and UMR825, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology and Neurosciences; University Hospital and University of Toulouse 3; France","institution_ids":["https://openalex.org/I4405258862"]},{"raw_affiliation_string":"INSERM CIC1436 and UMR825, Toulouse, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4405264399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050945427","display_name":"Santiago Perez\u2010Lloret","orcid":"https://orcid.org/0000-0001-9069-6512","observed_orcids":["https://orcid.org/0000-0001-9069-6512"]},"institutions":[{"id":"https://openalex.org/I151201029","display_name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","ror":"https://ror.org/03cqe8w59","country_code":"AR","type":"government","lineage":["https://openalex.org/I151201029","https://openalex.org/I4210123736","https://openalex.org/I4387155568"]},{"id":"https://openalex.org/I29406707","display_name":"Pontificia Universidad Cat\u00f3lica Argentina","ror":"https://ror.org/0422kzb24","country_code":"AR","type":"education","lineage":["https://openalex.org/I29406707"]}],"countries":["AR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Santiago Perez\u2010Lloret","raw_affiliation_strings":["Laboratory of Epidemiology and Experimental Pharmacology, Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA)","National Scientific and Technological Research Council (CONICET); Buenos Aires Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Epidemiology and Experimental Pharmacology, Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA)","institution_ids":["https://openalex.org/I29406707"]},{"raw_affiliation_string":"National Scientific and Technological Research Council (CONICET); Buenos Aires Argentina","institution_ids":["https://openalex.org/I151201029"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015724259","display_name":"Joaquim Jos\u00e9 Ferreira","orcid":"https://orcid.org/0000-0003-3950-5113","observed_orcids":["https://orcid.org/0000-0003-3950-5113"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]},{"id":"https://openalex.org/I4392738257","display_name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes","ror":"https://ror.org/019g8w217","country_code":"PT","type":"facility","lineage":["https://openalex.org/I141596103","https://openalex.org/I4392738257","https://openalex.org/I4405252639"]}],"countries":["PT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joaquim J Ferreira","raw_affiliation_strings":["Clinical Pharmacology Unit Instituto de Medicina Molecular Lisbon Portugal","Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Unit Instituto de Medicina Molecular Lisbon Portugal","institution_ids":["https://openalex.org/I4392738257"]},{"raw_affiliation_string":"Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5054027214"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4405258862","https://openalex.org/I4405264399"],"apc_list":{"value":4480,"currency":"USD","value_usd":4480},"apc_paid":null,"fwci":2.5506,"has_fulltext":false,"cited_by_count":127,"citation_normalized_percentile":{"value":0.92698827,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"30","issue":"11","first_page":"1451","last_page":"1460"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.007699999958276749,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13481","display_name":"Neurological diseases and metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/levodopa-induced-motor-complications","display_name":"levodopa-induced motor complications","score":0.9890000224113464},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9850000143051147},{"id":"https://openalex.org/keywords/motor-fluctuations","display_name":"motor fluctuations","score":0.968999981880188},{"id":"https://openalex.org/keywords/dyskinesia","display_name":"dyskinesia","score":0.9860000014305115},{"id":"https://openalex.org/keywords/safinamide","display_name":"safinamide","score":0.9490000009536743},{"id":"https://openalex.org/keywords/apomorphine","display_name":"apomorphine","score":0.746999979019165},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor-antagonist","display_name":"adenosine A2A receptor antagonists","score":0.9079999923706055},{"id":"https://openalex.org/keywords/istradefylline","display_name":"istradefylline","score":0.9369999766349792},{"id":"https://openalex.org/keywords/amantadine","display_name":"amantadine","score":0.949999988079071},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.8309999704360962},{"id":"https://openalex.org/keywords/eltoprazine","display_name":"eltoprazine","score":0.8299999833106995}],"concepts":[{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.8209540247917175},{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.8037943840026855},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6134482622146606},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5185137987136841},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4707278311252594},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.45906737446784973},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.4513010084629059},{"id":"https://openalex.org/C2777374534","wikidata":"https://www.wikidata.org/wiki/Q409761","display_name":"Amantadine","level":2,"score":0.4491729736328125},{"id":"https://openalex.org/C2776754145","wikidata":"https://www.wikidata.org/wiki/Q71133637","display_name":"Carbidopa","level":5,"score":0.4440142810344696},{"id":"https://openalex.org/C2776134090","wikidata":"https://www.wikidata.org/wiki/Q47495783","display_name":"Selegiline","level":4,"score":0.4376225769519806},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.385986328125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24652820825576782},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.21991810202598572}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/mds.26362","doi":"https://doi.org/10.1002/mds.26362","is_oa":false,"landing_page_url":"https://doi.org/10.1002/mds.26362","pdf_url":null,"source":{"id":"https://openalex.org/S163027424","display_name":"Movement Disorders","issn_l":"0885-3185","issn":["0885-3185","1531-8257"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement Disorders","raw_type":"journal-article"},{"id":"pmid:26293004","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26293004","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement disorders : official journal of the Movement Disorder Society","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W39072687","https://openalex.org/W85049043","https://openalex.org/W1493115321","https://openalex.org/W1533056363","https://openalex.org/W1547633323","https://openalex.org/W1577054006","https://openalex.org/W1605078502","https://openalex.org/W1631523450","https://openalex.org/W1727176495","https://openalex.org/W1732912328","https://openalex.org/W1947520742","https://openalex.org/W1963805455","https://openalex.org/W1967982382","https://openalex.org/W1969578096","https://openalex.org/W1969903608","https://openalex.org/W1971882460","https://openalex.org/W1974931028","https://openalex.org/W1975567689","https://openalex.org/W1981843268","https://openalex.org/W1985768488","https://openalex.org/W1994451481","https://openalex.org/W1999018495","https://openalex.org/W2004020527","https://openalex.org/W2005167173","https://openalex.org/W2007390314","https://openalex.org/W2021200219","https://openalex.org/W2028656651","https://openalex.org/W2033662966","https://openalex.org/W2036077803","https://openalex.org/W2049948842","https://openalex.org/W2061460058","https://openalex.org/W2062260389","https://openalex.org/W2068327908","https://openalex.org/W2079567207","https://openalex.org/W2081509710","https://openalex.org/W2084468949","https://openalex.org/W2085489039","https://openalex.org/W2087720405","https://openalex.org/W2089510050","https://openalex.org/W2101284751","https://openalex.org/W2107254875","https://openalex.org/W2108299953","https://openalex.org/W2108901766","https://openalex.org/W2109364412","https://openalex.org/W2109655049","https://openalex.org/W2110940529","https://openalex.org/W2115016444","https://openalex.org/W2115222037","https://openalex.org/W2121103728","https://openalex.org/W2122137453","https://openalex.org/W2124065800","https://openalex.org/W2124246462","https://openalex.org/W2129848379","https://openalex.org/W2135572887","https://openalex.org/W2136406052","https://openalex.org/W2138185463","https://openalex.org/W2139909171","https://openalex.org/W2143384631","https://openalex.org/W2161277679","https://openalex.org/W2163546102","https://openalex.org/W2334581933","https://openalex.org/W4211223857"],"related_works":["https://openalex.org/W2974008434","https://openalex.org/W2106983119","https://openalex.org/W3076047584","https://openalex.org/W1998838849","https://openalex.org/W4285587068","https://openalex.org/W2151727783","https://openalex.org/W1537019834","https://openalex.org/W1970320862","https://openalex.org/W4256377573"],"abstract_inverted_index":{"Levodopa":[0],"(l-dopa)-induced":[1],"motor":[2,5,75,106,137,189],"complications,":[3],"including":[4,43],"fluctuations":[6,190],"and":[7,33,45,68,101,130,153,185,197,233],"dyskinesia,":[8,202],"affect":[9],"almost":[10],"all":[11],"patients":[12,64,113],"with":[13,24,144,204],"Parkinson's":[14],"disease":[15,22],"(PD)":[16],"at":[17],"some":[18],"point":[19],"during":[20,59],"the":[21,60,89,210,213,241,260,268,271],"course,":[23],"relevant":[25],"implications":[26],"in":[27,112,194],"global":[28],"health":[29],"status.":[30],"Various":[31],"dopaminergic":[32],"nondopaminergic":[34,179],"pharmacological":[35,100],"approaches":[36],"as":[37,39,126,231,238],"well":[38],"more":[40],"invasive":[41],"strategies":[42],"devices":[44],"functional":[46],"surgery":[47],"are":[48,170],"available":[49],"to":[50,96,104,187,243,258,267],"manage":[51],"such":[52,125,230,237,247],"complications.":[53,107],"In":[54],"spite":[55],"of":[56,73,83,165,172,177,212,246,263,270,273],"undisputable":[57],"improvements":[58],"last":[61],"decades,":[62],"many":[63],"remain":[65],"significantly":[66],"disabled,":[67],"a":[69,145,154],"fully":[70],"satisfying":[71],"management":[72],"l-dopa-induced":[74],"complications":[76,118],"is":[77],"still":[78],"an":[79],"important":[80],"unmet":[81],"need":[82],"PD":[84],"therapy.":[85],"This":[86],"article":[87],"reviews":[88],"recent":[90],"trial":[91],"results":[92,140,193],"published":[93],"from":[94,115],"2013":[95],"April":[97],"2015":[98],"about":[99],"nonpharmacological":[102],"interventions":[103],"treat":[105,188],"Randomized":[108],"controlled":[109],"trials":[110,203,256],"conducted":[111,257],"suffering":[114],"already":[116],"established":[117],"showed":[119,191],"that":[120,162],"new":[121,146,163,205],"levodopa":[122],"(l-dopa)":[123],"formulations":[124,164,208],"intrajejunal":[127],"l-dopa-carbidopa":[128,133],"infusion":[129],"bilayered":[131],"extended-release":[132,207],"(IPX066)":[134],"can":[135],"improve":[136],"fluctuations.":[138],"Positive":[139,219],"were":[141,223],"also":[142,171,224],"obtained":[143],"monoamine":[147],"oxidase":[148],"B":[149],"(MAO-B)":[150],"inhibitor":[151,157],"(safinamide)":[152],"catechol-O-methyltransferase":[155],"COMT":[156],"(opicapone).":[158],"Pilot":[159],"data":[160],"suggest":[161],"dopamine":[166],"agonists":[167],"(inhaled":[168],"apomorphine)":[169],"potential":[173],"interest.":[174],"The":[175],"development":[176,272],"novel":[178],"adenosine":[180],"A2A":[181],"antagonists":[182],"(istradefylline,":[183],"preladenant,":[184],"tozadenant)":[186],"conflicting":[192],"phase":[195,198,254],"2":[196,255],"3":[199],"trials.":[200],"For":[201],"amantadine":[206],"confirmed":[209],"interest":[211],"glutamatergic":[214],"N-methyl-d-aspartate":[215],"(NMDA)":[216],"antagonist":[217],"approach.":[218],"pilot":[220],"antidyskinetic":[221],"effects":[222,262],"recently":[225],"reported":[226],"using":[227],"serotonin":[228],"agents":[229],"eltoprazine":[232],"glutamate":[234],"mGluR5":[235],"modulators":[236],"mavoglurant.":[239],"However,":[240],"translation":[242],"clinical":[244],"practice":[245],"innovative":[248],"concepts":[249],"remains":[250],"challenging,":[251],"because":[252],"subsequent":[253],"confirm":[259],"antidyskynetic":[261],"mavoglurant":[264],"failed,":[265],"leading":[266],"interruption":[269],"this":[274,277],"compound":[275],"for":[276],"indication.":[278]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1952010211","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":25},{"year":2016,"cited_by_count":20},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
